144 related articles for article (PubMed ID: 30969265)
1. Brincidofovir as a Salvage Therapy in Controlling Adenoviremia in Pediatric Recipients of Hematopoietic Stem Cell Transplant.
Meena JP; Phillips RS; Kinsey S
J Pediatr Hematol Oncol; 2019 Oct; 41(7):e467-e472. PubMed ID: 30969265
[TBL] [Abstract][Full Text] [Related]
2. Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial.
Grimley MS; Chemaly RF; Englund JA; Kurtzberg J; Chittick G; Brundage TM; Bae A; Morrison ME; Prasad VK
Biol Blood Marrow Transplant; 2017 Mar; 23(3):512-521. PubMed ID: 28063938
[TBL] [Abstract][Full Text] [Related]
3. The effect of cidofovir on adenovirus plasma DNA levels in stem cell transplantation recipients without T cell reconstitution.
Lugthart G; Oomen MA; Jol-van der Zijde CM; Ball LM; Bresters D; Kollen WJ; Smiers FJ; Vermont CL; Bredius RG; Schilham MW; van Tol MJ; Lankester AC
Biol Blood Marrow Transplant; 2015 Feb; 21(2):293-9. PubMed ID: 25464118
[TBL] [Abstract][Full Text] [Related]
4. Brincidofovir: understanding its unique profile and potential role against adenovirus and other viral infections.
Alvarez-Cardona JJ; Whited LK; Chemaly RF
Future Microbiol; 2020 Apr; 15():389-400. PubMed ID: 32166967
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and safety of intravenous cidofovir for life-threatening viral infections in pediatric hematopoietic stem cell transplant recipients.
Caruso Brown AE; Cohen MN; Tong S; Braverman RS; Rooney JF; Giller R; Levin MJ
Antimicrob Agents Chemother; 2015 Jul; 59(7):3718-25. PubMed ID: 25733509
[TBL] [Abstract][Full Text] [Related]
6. Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients.
Yusuf U; Hale GA; Carr J; Gu Z; Benaim E; Woodard P; Kasow KA; Horwitz EM; Leung W; Srivastava DK; Handgretinger R; Hayden RT
Transplantation; 2006 May; 81(10):1398-404. PubMed ID: 16732176
[TBL] [Abstract][Full Text] [Related]
7. Clinical and in vitro evaluation of cidofovir for treatment of adenovirus infection in pediatric hematopoietic stem cell transplant recipients.
Muller WJ; Levin MJ; Shin YK; Robinson C; Quinones R; Malcolm J; Hild E; Gao D; Giller R
Clin Infect Dis; 2005 Dec; 41(12):1812-6. PubMed ID: 16288409
[TBL] [Abstract][Full Text] [Related]
8. Brincidofovir is highly efficacious in controlling adenoviremia in pediatric recipients of hematopoietic cell transplant.
Hiwarkar P; Amrolia P; Sivaprakasam P; Lum SH; Doss H; O'Rafferty C; Petterson T; Patrick K; Silva J; Slatter M; Lawson S; Rao K; Steward C; Gassas A; Veys P; Wynn R;
Blood; 2017 Apr; 129(14):2033-2037. PubMed ID: 28153824
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus infection in pediatric transplant recipients: are effective antiviral agents coming our way?
Lopez SMC; Michaels MG; Green M
Curr Opin Organ Transplant; 2018 Aug; 23(4):395-399. PubMed ID: 29846196
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of brincidofovir as prophylaxis against HSV and VZV in hematopoietic cell transplant recipients.
Lee YJ; Neofytos D; Kim SJ; Cheteyan L; Huang YT; Papadopoulos EB; Jakubowski AA; Papanicolaou GA
Transpl Infect Dis; 2018 Dec; 20(6):e12977. PubMed ID: 30120866
[TBL] [Abstract][Full Text] [Related]
11. Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation.
Voigt S; Hofmann J; Edelmann A; Sauerbrei A; Kühl JS
Transpl Infect Dis; 2016 Oct; 18(5):791-794. PubMed ID: 27482652
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients.
Florescu DF; Pergam SA; Neely MN; Qiu F; Johnston C; Way S; Sande J; Lewinsohn DA; Guzman-Cottrill JA; Graham ML; Papanicolaou G; Kurtzberg J; Rigdon J; Painter W; Mommeja-Marin H; Lanier R; Anderson M; van der Horst C
Biol Blood Marrow Transplant; 2012 May; 18(5):731-8. PubMed ID: 21963623
[TBL] [Abstract][Full Text] [Related]
13. Disseminated adenovirus infection after allogeneic stem cell transplant and the potential role of brincidofovir - Case series and 10 year experience of management in an adult transplant cohort.
Ramsay ID; Attwood C; Irish D; Griffiths PD; Kyriakou C; Lowe DM
J Clin Virol; 2017 Nov; 96():73-79. PubMed ID: 29017084
[TBL] [Abstract][Full Text] [Related]
14. Brincidofovir as Salvage Therapy for Adenovirus Disease in Intestinal Transplant Recipients.
Sulejmani N; Nagai S; Safwan M; Rizzari MD; Raoufi M; Abouljoud MS; Ramesh M
Pharmacotherapy; 2018 Apr; 38(4):470-475. PubMed ID: 29457839
[TBL] [Abstract][Full Text] [Related]
15. Renal Toxicity in Pediatric Patients Receiving Cidofovir for the Treatment of Adenovirus Infection.
Vora SB; Brothers AW; Englund JA
J Pediatric Infect Dis Soc; 2017 Nov; 6(4):399-402. PubMed ID: 28419263
[TBL] [Abstract][Full Text] [Related]
16. Eradication of disseminated adenovirus infection in a pediatric hematopoietic stem cell transplantation recipient using the novel antiviral agent CMX001.
Paolino K; Sande J; Perez E; Loechelt B; Jantausch B; Painter W; Anderson M; Tippin T; Lanier ER; Fry T; DeBiasi RL
J Clin Virol; 2011 Feb; 50(2):167-70. PubMed ID: 21094081
[TBL] [Abstract][Full Text] [Related]
17. New drug on the horizon for treating adenovirus.
Wold WS; Toth K
Expert Opin Pharmacother; 2015; 16(14):2095-9. PubMed ID: 26330121
[TBL] [Abstract][Full Text] [Related]
18. Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir.
Symeonidis N; Jakubowski A; Pierre-Louis S; Jaffe D; Pamer E; Sepkowitz K; O'Reilly RJ; Papanicolaou GA
Transpl Infect Dis; 2007 Jun; 9(2):108-13. PubMed ID: 17461995
[TBL] [Abstract][Full Text] [Related]
19. Poor outcome of adenovirus infections in adult hematopoietic stem cell transplant patients with sustained adenovirus viremia.
Omar H; Yun Z; Lewensohn-Fuchs I; Pérez-Bercoff L; Orvell C; Engström L; Vuong GK; Ljungman P
Transpl Infect Dis; 2010 Oct; 12(5):465-9. PubMed ID: 20553439
[TBL] [Abstract][Full Text] [Related]
20. Safety and tolerability of cidofovir in high-risk pediatric patients.
Bhadri VA; Lee-Horn L; Shaw PJ
Transpl Infect Dis; 2009 Aug; 11(4):373-9. PubMed ID: 19392729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
